Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

for
Chronic Kidney Disease
Location: Philadelphia PA, Kansas City MO
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: All

Age: 0 - 22

Code: NCT00327860

Recruiting
Active & Responsive

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

for
Somatostatin Receptor Positive, NETs, Lymphoma, Solid Tumor,
Location: Philadelphia PA, Houston TX, San Francisco CA
Sponsor: ITM Solucin GmbH

Sex: All

Age: 2 - 18

Code: NCT06441331

Phase1, Recruiting
Active & Responsive

Study of LNP.UCD.ABE in Patients With Urea Cycle Disorders

for
Urea Cycle Disorders, Carbamoyl-Phosphate Synthase I Deficiency
Location: Philadelphia PA
Sponsor: Rebecca Ahrens-Nicklas

Sex: All

Age: 0 - 5

Code: NCT07667387

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia

for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: Philadelphia PA, New York NY, Dallas TX, Palo Alto CA
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 1 - 17

Code: NCT07517133

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

for
Transfusion-dependent Alpha-Thalassemia,
Location: Philadelphia PA, New York NY, Dallas TX
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 1 - 17

Code: NCT07506863

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Removing Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids

for
Cardiac Arrest, Anxiety Depression, Family Support
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 17

Code: NCT07707037

Recruiting
Active & Responsive

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

for
Acute Myeloid Leukemia (AML)
Location: Philadelphia PA
Sponsor: Stephan Grupp MD PhD

Sex: All

Age: 0 - 29

Code: NCT07464951

Phase1, Recruiting
Active & Responsive

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

for
High-Risk Neuroblastoma
Location: Philadelphia PA, The Bronx NY, Toronto, Durham NC,
Sponsor: Renaissance Pharma Ltd.

Sex: All

Age: 1 - 18

Code: NCT07549321

Phase2, Phase3, Recruiting
Active & Responsive

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

for
Patient-Reported Outcome Measures (PROMs), Pragmatic Trial,
Location: Philadelphia PA, New York NY, Pittsburgh PA, Boston MA,
Sponsor: Carelon Research

Sex: All

Age: 12 - 17

Code: NCT07525843

Recruiting
Active & Responsive

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

for
Neonatal Opioid Withdrawal Syndrome
Location: Philadelphia PA, Lexington KY, Indianapolis IN,
Sponsor: HELP for NOWS Consortium

Sex: All

Age: 0+

Code: NCT07278375

Recruiting
Active & Responsive

Urinary Titin Biomarker in DMD

for
Duchenne Muscular Dystrophy (DMD),
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: Male

Age: 2 - 10

Code: NCT07332013

Recruiting
Active & Responsive

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for
Congenital Adrenal Hyperplasia,
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 1 - 17

Code: NCT07159841

Phase2, Phase3, Recruiting
Active & Responsive

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

for
Cytomegalovirus Prophylaxis
Location: Philadelphia PA, New York NY, The Bronx NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07199465

Phase1, Recruiting
Active & Responsive

A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

for
Danon Disease
Location: Philadelphia PA, Boston MA, La Jolla CA
Sponsor: Rocket Pharmaceuticals Inc.

Sex: Male

Age: 8+

Code: NCT06092034

Phase2, Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: Philadelphia PA, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase3, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Philadelphia PA, Wilmington DE, New York NY,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase3, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Philadelphia PA, New Brunswick NJ, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase3, Recruiting
Active & Responsive

Pediatric Post-Approval Registry

for
Obstructive Sleep Apnea
Location: Philadelphia PA, Sewickley PA, Norfolk VA, Durham NC,
Sponsor: Inspire Medical Systems, Inc.

Sex: All

Age: 18 - 21

Code: NCT04457154

Recruiting
Active & Responsive

A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering

for
Scoliosis Idiopathic
Location: Philadelphia PA, New York NY, Washington DC, Ottawa,
Sponsor: Pediatric Spine Foundation

Sex: All

Age: 0 - 18

Code: NCT04914507

Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Philadelphia PA, New York NY, Baltimore MD, Boston MA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase2, Recruiting